Four diagnostic markers (LRRTM4, PTPN22, FAM175B, and PROM2) for DCM were identified with high AUC values, indicating their potential regulatory significance in DCM pathogenesis. This evidence concerns the gene PROM2 and familial dilated cardiomyopathy.